HLA homozygosity does not adversely affect measles vaccine-induced cytokine responses

Virology

Volumn 364, Issue 1, 2007, Pages 87-94

  Ovsyannikova, Inna G ^a   Jacobson, Robert M ^a,b   Dhiman, Neelam ^a   Vierkant, Robert A ^b   Pankratz, V Shane ^b   Poland, Gregory A ^a,b  

^a MAYO CLINIC   (United States)

^b Mayo Clinic   (United States)

Author keywords

Cytokines; HLA; Homozygosity; Measles vaccine; Measles virus

Indexed keywords

CYTOKINE; GAMMA INTERFERON; HLA DP ANTIGEN; HLA DPA1 ANTIGEN; HLA DPB1 ANTIGEN; HLA DQA1 ANTIGEN; HLA DR ANTIGEN; INTERLEUKIN 10; INTERLEUKIN 12P40; INTERLEUKIN 2; INTERLEUKIN 4; MEASLES MUMPS RUBELLA VACCINE; MEASLES VACCINE; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; GENE LOCUS; HETEROZYGOSITY; HLA SYSTEM; HOMOZYGOSITY; HUMAN; HUMAN EXPERIMENT; IMMUNE RESPONSE; IMMUNIZATION; MEASLES VIRUS; NORMAL HUMAN; PRIORITY JOURNAL; SCHOOL CHILD; TH1 CELL; TH2 CELL;

ADOLESCENT; CHILD; CYTOKINES; FEMALE; GENES, MHC CLASS I; GENES, MHC CLASS II; HETEROZYGOTE; HLA ANTIGENS; HOMOZYGOTE; HUMANS; INTERFERON TYPE II; INTERLEUKIN-10; INTERLEUKIN-12 SUBUNIT P40; INTERLEUKIN-2; INTERLEUKIN-4; MALE; MEASLES VACCINE; TH1 CELLS; TH2 CELLS;

MEASLES VIRUS;

EID: 34249709527     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2007.02.028     Document Type: Article

References (43)

1. Carrington M., and O'Brien S.J. The influence of HLA genotype on AIDS. Annu. Rev. Med. 54 (2003) 535-551
2. Chicz R.M., Urban R.G., Gorga J.C., Vignali D.A.A., Lane W.S., and Strominger J.L. Specificity and promiscuity among naturally processed peptides bound to HLA-DR alleles. J. Exp. Med. 178 (1993) 27-47
3. Dhiman N., Ovsyannikova I.G., Howe R.C., Ryan J.E., Jacobson R.M., and Poland G.A. Interleukin-4 induced by measles virus and measles-derived peptides as measured by IL-4 receptor-blocking ELISA. J. Immunol. Methods 287 (2004) 217-225
4. 2 cytokine responses following MMR-II vaccination. Clin. Exp. Immunol. 142 (2005) 498-504
5. Gelder C.M., Lambkin R., Hart K.W., Fleming D., Williams O.M., Bunce M., Welsh K.I., Marshall S.E., and Oxford J. Associations between human leukocyte antigens and nonresponsiveness to influenza vaccine. J. Infect. Dis. 185 (2002) 114-117
6. Guo S.W., and Thompson E.A. Performing the exact test of Hardy-Weinberg proportion for multiple alleles. Biometrics 48 (1992) 361-372
7. Hill C.M., Liu A., Marshall K.W., Mayer J., Jorgensen B., Yuan B., Cubbon R.M., Nichols E.A., Wicker L.S., and Rothbard J.B. Exploration of requirements for peptide binding to HLA DRB1*0101 and DRB1*0401. J. Immunol. 152 (1994) 2890-2898
8. 1-like cytokine responses in vitro to measles virus. Clin. Exp. Immunol. 140 (2005) 333-342
9. 0 cells responding to measles virus. Hum. Immunol. 66 (2005) 104-115
10. Hughes A.L., Yeager M., and Carrington M. Peptide binding function and the paradox of HLA disease associations. Immunol. Cell Biol. 74 (1996) 444-448
11. Jacobson R.M., Poland G.A., Vierkant R.A., Pankratz V.S., Schaid D.J., Jacobsen S.J., St.Sauver J.L., and Moore S.B. The association of class I HLA alleles and antibody levels following a single dose of measles vaccine. Hum. Immunol. 64 (2003) 103-109
12. Karp C.L., Wysocka M., Wahl L.M., Ahearn J.M., Cuomo P.J., Sherry B., Trinchieri G., and Griffin D.E. Mechanism of suppression of cell-mediated immunity by measles virus. Science 273 (1996) 228-231
13. Kaslow R.A., Rivers C., Tang J., Bender T.J., Goepfert P.A., El Habib R., Weinhold K., and Mulligan M.J. Polymorphisms in HLA class I genes associated with both favorable prognosis of human immunodeficiency virus (HIV) type 1 infection and positive cytotoxic T-lymphocyte responses to ALVAC-HIV recombinant canarypox vaccines. J. Virol. 75 (2001) 8681-8689
14. Kruskall M.S., Alper C.A., Awdeh Z., Yunis E.J., and Marcus-Bagley D. The immune response to hepatitis B vaccine in humans: Inheritance patterns in families. J. Exp. Med. 175 (1992) 495-502
15. Lindemann M., Barsegian V., Siffert W., Ferencik S., Roggendorf M., and Grosse-Wilde H. Role of G protein beta3 subunit C825T and HLA class II polymorphisms in the immune response after HBV vaccination. Virology 297 (2002) 245-252
16. Marshall K.W., Liu A.F., Canales J., Perahia B., Jorgensen B., Gantzos R.D., Aguilar B., Devaux B., and Rothbard J.B. Role of the polymorphic residues in HLA-DR molecules in allele-specific binding of peptide ligands. J. Immunol. 152 (1994) 4946-4957
17. 1-cell epitopes from the secreted Mycobacterium tuberculosis antigen 85B recognized by antigen-specific human CD4(+) T-cell lines. Infect. Immun. 68 (2000) 3933-3940
18. Nepom B.S., Nepom G.T., Coleman M., and Kwok W.W. Critical contribution of β chain residue 57 in peptide binding ability of both HLA-DR and -DQ molecules. Proc. Natl. Acad. Sci. U.S.A. 93 (1996) 7202-7206
19. Newport M.J., Goetghebuer T., Weiss H.A., Whittle H., Siegrist C.-A., Marchant A., and The MRC Gambia Twin Study Group. Genetic regulation of immune responses to vaccines in early life. Genes Immun. 5 (2004) 122-129
20. O'Sullivan D., Arrhenius T., Sidney J., del Guercio M.F., Albertson M., Wall M., Oseroff C., Southwood S., Colon S.M., and Gaeta F.C. On the interaction of promiscuous antigenic peptides with different DR alleles. Identification of common structural motifs. J. Immunol. 147 (1991) 2663-2669
21. Ou D., Mitchell L.A., and Tingle A.J. A new categorization of HLA DR alleles on a functional basis. Hum. Immunol. 59 (1998) 665-676
22. Ovsyannikova I.G., Jacobson R.M., Vierkant R.A., Jacobsen S.J., Pankratz V.S., and Poland G.A. The contribution of HLA class I antigens in immune status following two doses of rubella vaccination. Hum. Immunol. 65 (2004) 1506-1515
23. Ovsyannikova I.G., Jacobson R.M., Vierkant R.A., Pankratz S.V., Jacobsen S.J., and Poland G.A. Associations between human leukocyte antigen (HLA) alleles and very high levels of measles antibody following vaccination. Vaccine 22 (2004) 1914-1920
24. Ovsyannikova I.G., Jacobson R.M., Ryan J.E., Vierkant R.A., Pankratz V.S., Jacobsen S.J., and Poland G.A. HLA class II alleles and measles virus-specific cytokine immune response following two doses of measles vaccine. Immunogenetics 56 (2005) 798-807
25. Polack F.P., Hoffman S.J., Moss W.J., and Griffin D.E. Altered synthesis of interleukin-12 and type 1 and type 2 cytokines in rhesus macaques during measles and atypical measles. J. Infect. Dis. 185 (2002) 13-19
26. Poland G.A., Ovsyannikova I.G., Jacobson R.M., Vierkant R.A., Jacobsen S.J., Pankratz V.S., and Schaid D.J. Identification of an association between HLA class II alleles and low antibody levels after measles immunization. Vaccine 20 (2001) 430-438
27. Schuenke K.W., Cook R.G., and Rich R.R. Binding specificity of a class II-restricted hepatitis B epitope by DR molecules from responder and nonresponder vaccine recipients. Hum. Immunol. 59 (1998) 783-793
28. Sette A., and Sidney J. Nine major HLA class I supertypes account for the vast preponderance of HLA-A and -B polymorphism. Immunogenetics 50 (1999) 201-212
29. Sette A., Vitiello A., Farness P., Furze J., Sidney J., Claverie J.M., Grey H.M., and Chesnut R. Random association between the peptide repertoire of A2.1 class I and several different DR class II molecules. J. Immunol. 147 (1991) 3893-3900
30. Sidney J., del Guercio M.F., Southwood S., Engelhard V.H., Appella E., Rammensee H.G., Falk K., Rotzschke O., Takiguchi M., and Kubo R.T. Several HLA alleles share overlapping peptide specificities. J. Immunol. 154 (1995) 247-259
31. Sidney J., Grey H.M., Southwood S., Celis E., Wentworth P.A., del Guercio M.-F., Kubo R.T., Chesnut R.W., and Sette A. Definition of an HLA-A3-like supermotif demonstrates the overlapping peptide-binding repertoires of common HLA molecules. Hum. Immunol. 45 (1996) 79-93
32. Southwood S., Sidney J., Kondo A., del Guercio M.F., Appella E., Hoffman S., Kubo R.T., Chesnut R.W., Grey H.M., and Sette A. Several common HLA-DR types share largely overlapping peptide binding repertoires. J. Immunol. 160 (1998) 3363-3373
33. St.Sauver J.L., Ovsyannikova I.G., Jacobson R.M., Jacobsen S.J., Vierkant R.A., Schaid D.J., Pankratz V.S., Green E.M., and Poland G.A. Associations between human leukocyte antigen homozygosity and antibody levels to measles vaccine. J. Infect. Dis. 185 (2002) 1545-1549
34. St.Sauver J.L., Dhiman N., Ovsyannikova I.G., Jacobson R.M., Vierkant R.A., Pankratz S.V., Jacobsen S.J., and Poland G.A. Extinction of the human leukocyte antigen homozygosity effect after two doses of the measles-mumps-rubella vaccine. Hum. Immunol. 66 (2005) 788-798
35. St.Sauver, J.L., Jacobsen, S.J., Jacobson, R.M., Vierkant, R.A., Ovsyannikova, I.G., Dhiman, N., and Poland, G.A., in press. Assessing volunteer and recruitment bias in a population-based study of measles-mumps-rubella vaccine immunity in children and adolescents. Paediatric and Perinatal Epidemiology.
36. Stachowski J., Kramer J., Füst G., Maciejewski J., Baldmus C.A., and Petrányi G.G. Relationship between the reactivity to hepatitis B virus vaccination and the frequency of MHC class I, II and III alleles in haemodialysis patients. Scand. J. Immunol. 42 (1995) 60-65
37. Tang J.M., Costello C., Keet I.P.M., Rivers C., LeBlanc S., Karita E., Allen S., and Kaslow R.A. HLA class I homozygosity accelerates disease progression in human immunodeficiency virus type I infection. AIDS Res. Hum. Retroviruses 15 (1999) 317-324
38. Thursz M.R., Thomas H.C., Greenwood B.M., and Hill A.V.S. Heterozygote advantage for HLA class-II type in hepatitis B virus infection. Nat. Genet. 17 (1997) 11-12
39. Trachtenberg E., Korber B., Sollars C., Kepler T.B., Hraber P.T., Hayes E., Funkhouser R., Fugate M., Theiler J., Hsu Y.S., Kunstman K., Wu S., Phair J., Erlich H., and Wolinsky S. Advantage of rare HLA supertype in HIV disease progression. Nat. Med. 9 (2003) 928-935
40. 1 cytokine production. Immunol. Lett. 39 (1994) 163-168
41. Vingerhoets J., Goilav C., Vanham G., Kestens L., Muylle L., Kegels E., Van Hoof J., Piot P., and Gigase P. Non-response to a recombinant pre-S2-containing hepatitis B vaccine: association with the HLA-system. Ann. Soc. Belge Méd. Trop. 75 (1995) 125-129
42. Wang C., Tang J., Song W., Lobashevsky E., Wilson C.M., and Kaslow R.A. HLA and cytokine gene polymorphisms are independently associated with responses to hepatitis B vaccination. Hepatology 39 (2004) 978-988
43. Yassine-Diab B., Carmichael P., L'Faqihi F.-E., Lombardi G., Deacock S., de Préval C., Coppin H., and Lechler R.I. Biased T-cell receptor usage is associated with allelic variation in the MHC class II peptide binding grove. Immunogenetics 49 (1999) 532-540